These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38361351)

  • 21. Multi-Beat Right Ventricular-Arterial Coupling Predicts Clinical Worsening in Pulmonary Arterial Hypertension.
    Hsu S; Simpson CE; Houston BA; Wand A; Sato T; Kolb TM; Mathai SC; Kass DA; Hassoun PM; Damico RL; Tedford RJ
    J Am Heart Assoc; 2020 May; 9(10):e016031. PubMed ID: 32384024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Systematic Review of Novel Therapies of Pulmonary Arterial Hypertension.
    Nabeh OA; Saud AI; Amin B; Khedr AS; Amr A; Faoosa AM; Esmat E; Mahmoud YM; Hatem A; Mohamed M; Osama A; Soliman YMA; Elkorashy RI; Elmorsy SA
    Am J Cardiovasc Drugs; 2024 Jan; 24(1):39-54. PubMed ID: 37945977
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Peng Y; Dai J; Zhao YY
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. β3 adrenergic agonism: A novel pathway which improves right ventricular-pulmonary arterial hemodynamics in pulmonary arterial hypertension.
    Karimi Galougahi K; Zhang Y; Kienzle V; Liu CC; Quek LE; Patel S; Lau E; Cordina RL; Figtree GA; Celermajer DS
    Physiol Rep; 2023 Jan; 11(1):e15549. PubMed ID: 36597221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The REPAIR Study: Effects of Macitentan on RV Structure and Function in Pulmonary Arterial Hypertension.
    Vonk Noordegraaf A; Channick R; Cottreel E; Kiely DG; Marcus JT; Martin N; Moiseeva O; Peacock A; Swift AJ; Tawakol A; Torbicki A; Rosenkranz S; Galiè N
    JACC Cardiovasc Imaging; 2022 Feb; 15(2):240-253. PubMed ID: 34801462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Right Ventricular and Right Atrial Function Are Less Compromised in Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction: A Comparison With Pulmonary Arterial Hypertension With Similar Pressure Overload.
    van Wezenbeek J; Kianzad A; van de Bovenkamp A; Wessels J; Mouratoglou SA; Braams NJ; Jansen SMA; Meulblok E; Meijboom LJ; Marcus JT; Vonk Noordegraaf A; José Goumans M; Jan Bogaard H; Handoko ML; de Man FS
    Circ Heart Fail; 2022 Feb; 15(2):e008726. PubMed ID: 34937392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to-Mesenchymal Transition in Human Right Ventricular Failure.
    Park JF; Clark VR; Banerjee S; Hong J; Razee A; Williams T; Fishbein G; Saddic L; Umar S
    Circ Heart Fail; 2021 Feb; 14(2):e007058. PubMed ID: 33541093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Right ventricular-pulmonary arterial coupling ratio derived from 3-dimensional echocardiography predicts outcomes in systemic lupus erythematosus-associated pulmonary arterial hypertension patients.
    Lan WF; Deng Y; Dai P; Wu DD; Hu J; Liao J; Meng H
    Lupus; 2024 Feb; 33(2):155-165. PubMed ID: 38182135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment Discontinuation or Interruption in Pulmonary Arterial Hypertension.
    Narechania S; Torbic H; Tonelli AR
    J Cardiovasc Pharmacol Ther; 2020 Mar; 25(2):131-141. PubMed ID: 31594400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring Pulmonary Arterial Hypertension Using an Implantable Hemodynamic Sensor.
    Benza RL; Doyle M; Lasorda D; Parikh KS; Correa-Jaque P; Badie N; Ginn G; Airhart S; Franco V; Kanwar MK; Murali S; Raina A; Agarwal R; Rajagopal S; White J; Biederman R
    Chest; 2019 Dec; 156(6):1176-1186. PubMed ID: 31265832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effects of mesenchymal stem cell delivery via a novel cardiac bioscaffold on right ventricles of pulmonary arterial hypertensive rats.
    Schmuck EG; Hacker TA; Schreier DA; Chesler NC; Wang Z
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1005-H1013. PubMed ID: 30822119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension.
    Sun XQ; Peters EL; Schalij I; Axelsen JB; Andersen S; Kurakula K; Gomez-Puerto MC; Szulcek R; Pan X; da Silva Goncalves Bos D; Schiepers REJ; Andersen A; Goumans MJ; Vonk Noordegraaf A; van der Laarse WJ; de Man FS; Bogaard HJ
    Am J Respir Cell Mol Biol; 2021 Mar; 64(3):331-343. PubMed ID: 33264068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-Term Effects of Inhaled Nitric Oxide on Right Ventricular Flow Hemodynamics by 4-Dimensional-Flow Magnetic Resonance Imaging in Children With Pulmonary Arterial Hypertension.
    Schäfer M; Frank BS; Ivy DD; Abman SH; Stenmark KR; Mitchell MB; Browne LP; Barker AJ; Hunter KS; Kheyfets V; Miller-Reed K; Ing R; Morgan GJ; Truong U
    J Am Heart Assoc; 2021 Apr; 10(8):e020548. PubMed ID: 33821682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Right ventricle-pulmonary artery coupling in pulmonary artery hypertension its measurement and pharmacotherapy.
    Sandeep B; Cheng H; Yan Y; Huang X; Wu Q; Gao K; Xiao Z
    Curr Probl Cardiol; 2024 Apr; 49(4):102425. PubMed ID: 38311275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic profiling of in vivo right ventricular function and exercise performance in pulmonary arterial hypertension.
    Simpson CE; Coursen J; Hsu S; Gough EK; Harlan R; Roux A; Aja S; Graham D; Kauffman M; Suresh K; Tedford RJ; Kolb TM; Mathai SC; Hassoun PM; Damico RL
    Am J Physiol Lung Cell Mol Physiol; 2023 Jun; 324(6):L836-L848. PubMed ID: 37070742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ECG in the clinical and prognostic evaluation of patients with pulmonary arterial hypertension: an underestimated value.
    Michalski TA; Pszczola J; Lisowska A; Knapp M; Sobkowicz B; Kaminski K; Ptaszynska-Kopczynska K
    Ther Adv Respir Dis; 2022; 16():17534666221087846. PubMed ID: 35442108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage-NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension.
    Al-Qazazi R; Lima PDA; Prisco SZ; Potus F; Dasgupta A; Chen KH; Tian L; Bentley RET; Mewburn J; Martin AY; Wu D; Jones O; Maurice DH; Bonnet S; Provencher S; Prins KW; Archer SL
    Am J Respir Crit Care Med; 2022 Sep; 206(5):608-624. PubMed ID: 35699679
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of Oxygen Starvation in Right Ventricular Decompensation and Failure in Pulmonary Arterial Hypertension.
    Oknińska M; Zajda K; Zambrowska Z; Grzanka M; Paterek A; Mackiewicz U; Szczylik C; Kurzyna M; Piekiełko-Witkowska A; Torbicki A; Kieda C; Mączewski M
    JACC Heart Fail; 2024 Feb; 12(2):235-247. PubMed ID: 37140511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Considerations for Inotrope and Vasopressor Use in Critically Ill Patients With Pulmonary Arterial Hypertension.
    Adie SK; Abdul-Aziz AA; Ketcham SW; Moles VM
    J Cardiovasc Pharmacol; 2022 Jan; 79(1):e11-e17. PubMed ID: 34654789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An emerging class of new therapeutics targeting TGF, Activin, and BMP ligands in pulmonary arterial hypertension.
    Upton PD; Dunmore BJ; Li W; Morrell NW
    Dev Dyn; 2023 Mar; 252(3):327-342. PubMed ID: 35434863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.